45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
765
Insurances with rates
15
CPT / HCPCS codes
149
Source MRF
Most expensive procedures (gross)
143134
$26,260
Tildrakizumab-asmn Subcutaneous Soln Pref Syringe 100 MG/ML
Gross
$26,260
148337
$21,418
Daratumumab-Hyaluronidase-fihj Inj 1800-30000 MG-Unit/15ML
Gross
$21,418
128449
$16,599
Vedolizumab For IV Solution 300 MG
Gross
$16,599
148648
$16,365
Lurbinectedin For IV Soln 4 MG
Gross
$16,365
153062
$12,819
Efgartigimod alfa-fcab IV Soln 400 MG/20ML
Gross
$12,819
Respiratory infections and inflammations with ma
$12,763
Respiratory infections and inflammations with major complications
Gross
$12,763
Heart failure & shock without complications
$10,507
Heart failure & shock without complications
Gross
$10,507
130696
$10,487
Pembrolizumab IV Soln 100 MG/4ML (25 MG/ML)
Gross
$10,487
4902216
$10,264
HC LAPAROSCOPIC CHOLECYSTECTOMY
Gross
$10,264
111065
$9,425
Panitumumab IV Soln 400 MG/20ML
Gross
$9,425
24435
$9,127
Octreotide Acetate For IM Inj Kit 20 MG
Gross
$9,127
General symptoms of illness such as fever, pain,
$8,975
General symptoms of illness such as fever, pain, shortness of breath
Gross
$8,975
139944
$8,782
Durvalumab Soln for IV Infusion 500 MG/10ML (50 MG/ML)
Gross
$8,782
109717
$6,897
Denosumab Inj 120 MG/1.7ML
Gross
$6,897
149123
$6,856
Ferric Derisomaltose (One Dose) IV Sol 1000 MG/10ML (Fe Eq)
Gross
$6,856
145223
$6,638
Romosozumab-aqqg Inj Soln Prefilled Syringe 105 MG/1.17ML
Gross
$6,638
4902264
$6,583
HC RPR INITIAL HERNIA >5 YRS STRANG
Gross
$6,583
111071
$6,126
Tocilizumab IV Inj 400 MG/20ML
Gross
$6,126
Head trauma w coma >1 hr or hemorrhage [Moderate
$5,657
Head trauma w coma >1 hr or hemorrhage [Moderate Severity]
Gross
$5,657
125072
$4,626
Golimumab IV Soln 50 MG/4ML
Gross
$4,626
111063
$4,256
Panitumumab IV Soln 100 MG/5ML
Gross
$4,256
142968
$4,167
Pegfilgrastim-jmdb Soln Prefilled Syringe 6 MG/0.6ML
Gross
$4,167
144893
$4,135
Denosumab Inj Soln Prefilled Syringe 60 MG/ML
Gross
$4,135
J0897
$3,726
PR DENOSUMAB INJECTION, 1MG
Gross
$3,726
111070
$3,467
Tocilizumab IV Inj 200 MG/10ML
Gross
$3,467
10392
$3,465
Leuprolide Acetate For Inj Kit 7.5 MG
Gross
$3,465
6100002
$3,339
HC MRI ORBIT/FACE/NECK W/WO DYE
Gross
$3,339
6100033
$3,264
HC MRI ABDOMEN W/WO DYE
Gross
$3,264
6120006
$3,041
HC MRI C-SPINE W/WO DYE
Gross
$3,041
6100029
$2,993
HC MRI LOWER EXT JOINT W/WO DYE
Gross
$2,993
6110003
$2,895
HC MRI-BRAIN W/WO DYE
Gross
$2,895
4900047
$2,782
HC EXC SKIN BENIG >4CM TRUNK,ARM,LEG
Gross
$2,782
3520037
$2,552
HC CT ABD/PELVIS W/O&W CONTRAST
Gross
$2,552
155974
$2,520
Semaglutide Soln Pen-inj 0.25 or 0.5 MG/DOSE (2 MG/3ML)
Gross
$2,520
125094
$2,439
Ferric Carboxymaltose IV Soln 750 MG/15ML (Fe Equivalent)
Gross
$2,439
3520036
$2,234
HC CT ABD/PELVIS W/CONTRAST
Gross
$2,234
6100024
$2,199
HC MRI LOWER EXT W/O DYE
Gross
$2,199
3500005
$2,066
HC CTA CHEST
Gross
$2,066
40801
$2,035
Leuprolide Acetate (6 Month) For Subcutaneous Inj Kit 45 MG
Gross
$2,035
3500003
$2,032
HC CTA HEAD
Gross
$2,032
PC3100060
$1,943
PC MESH: IMPLANTABLE
Gross
$1,943
6100031
$1,930
HC MRI-ABDOMEN W/O DYE
Gross
$1,930
PC86366
$1,775
PC MUSK AUTOANTIBODY, S
Gross
$1,775
6100020
$1,773
HC MRI-UPPER EXT JOINT W/O DYE
Gross
$1,773
6100027
$1,773
HC MRI-LOWER EXT JOINT W/O DYE
Gross
$1,773
3520002
$1,750
HC CT THORAX W+WO CONTRAST
Gross
$1,750
3520005
$1,724
HC CT PELVIS W/DYE
Gross
$1,724
6110001
$1,717
HC MRI-BRAIN/BRAIN STEM
Gross
$1,717
3510003
$1,653
HC CT ORBITS/FOSSA/SELLA/IAC
Gross
$1,653
6120000
$1,649
HC MRI-C-SPINE W/O DYE
Gross
$1,649
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 143134 | Tildrakizumab-asmn Subcutaneous Soln Pref Syringe 100 MG/ML | $26,260 | $26,260 | — | — | 1 |
| 148337 | Daratumumab-Hyaluronidase-fihj Inj 1800-30000 MG-Unit/15ML | $21,418 | $21,418 | — | — | 1 |
| 128449 | Vedolizumab For IV Solution 300 MG | $16,599 | $16,599 | — | — | 1 |
| 148648 | Lurbinectedin For IV Soln 4 MG | $16,365 | $16,365 | — | — | 1 |
| 153062 | Efgartigimod alfa-fcab IV Soln 400 MG/20ML | $12,819 | $12,819 | — | — | 1 |
| Respiratory infections and inflammations with ma | Respiratory infections and inflammations with major complications | $12,763 | $12,763 | — | — | 1 |
| Heart failure & shock without complications | Heart failure & shock without complications | $10,507 | $10,507 | — | — | 1 |
| 130696 | Pembrolizumab IV Soln 100 MG/4ML (25 MG/ML) | $10,487 | $10,487 | — | — | 2 |
| 4902216 | HC LAPAROSCOPIC CHOLECYSTECTOMY | $10,264 | $10,264 | — | — | 2 |
| 111065 | Panitumumab IV Soln 400 MG/20ML | $9,425 | $9,425 | — | — | 1 |
| 24435 | Octreotide Acetate For IM Inj Kit 20 MG | $9,127 | $9,127 | — | — | 1 |
| General symptoms of illness such as fever, pain, | General symptoms of illness such as fever, pain, shortness of breath | $8,975 | $8,975 | — | — | 1 |
| 139944 | Durvalumab Soln for IV Infusion 500 MG/10ML (50 MG/ML) | $8,782 | $8,782 | — | — | 1 |
| 109717 | Denosumab Inj 120 MG/1.7ML | $6,897 | $6,897 | — | — | 8 |
| 149123 | Ferric Derisomaltose (One Dose) IV Sol 1000 MG/10ML (Fe Eq) | $6,856 | $6,856 | — | — | 1 |
| 145223 | Romosozumab-aqqg Inj Soln Prefilled Syringe 105 MG/1.17ML | $6,638 | $6,638 | — | — | 2 |
| 4902264 | HC RPR INITIAL HERNIA >5 YRS STRANG | $6,583 | $6,583 | — | — | 1 |
| 111071 | Tocilizumab IV Inj 400 MG/20ML | $6,126 | $6,126 | — | — | 1 |
| Head trauma w coma >1 hr or hemorrhage [Moderate | Head trauma w coma >1 hr or hemorrhage [Moderate Severity] | $5,657 | $5,657 | — | — | 1 |
| 125072 | Golimumab IV Soln 50 MG/4ML | $4,626 | $4,626 | — | — | 2 |
| 111063 | Panitumumab IV Soln 100 MG/5ML | $4,256 | $4,256 | — | — | 1 |
| 142968 | Pegfilgrastim-jmdb Soln Prefilled Syringe 6 MG/0.6ML | $4,167 | $4,167 | — | — | 1 |
| 144893 | Denosumab Inj Soln Prefilled Syringe 60 MG/ML | $4,135 | $4,135 | — | — | 8 |
| J0897 | PR DENOSUMAB INJECTION, 1MG | $3,726 | $3,726 | — | — | 8 |
| 111070 | Tocilizumab IV Inj 200 MG/10ML | $3,467 | $3,467 | — | — | 1 |
| 10392 | Leuprolide Acetate For Inj Kit 7.5 MG | $3,465 | $3,465 | — | — | 4 |
| 6100002 | HC MRI ORBIT/FACE/NECK W/WO DYE | $3,339 | $3,339 | — | — | 2 |
| 6100033 | HC MRI ABDOMEN W/WO DYE | $3,264 | $3,264 | — | — | 4 |
| 6120006 | HC MRI C-SPINE W/WO DYE | $3,041 | $3,041 | — | — | 1 |
| 6100029 | HC MRI LOWER EXT JOINT W/WO DYE | $2,993 | $2,993 | — | — | 2 |
| 6110003 | HC MRI-BRAIN W/WO DYE | $2,895 | $2,895 | — | — | 7 |
| 4900047 | HC EXC SKIN BENIG >4CM TRUNK,ARM,LEG | $2,782 | $2,782 | — | — | 1 |
| 3520037 | HC CT ABD/PELVIS W/O&W CONTRAST | $2,552 | $2,552 | — | — | 4 |
| 155974 | Semaglutide Soln Pen-inj 0.25 or 0.5 MG/DOSE (2 MG/3ML) | $2,520 | $2,520 | — | — | 4 |
| 125094 | Ferric Carboxymaltose IV Soln 750 MG/15ML (Fe Equivalent) | $2,439 | $2,439 | — | — | 2 |
| 3520036 | HC CT ABD/PELVIS W/CONTRAST | $2,234 | $2,234 | — | — | 14 |
| 6100024 | HC MRI LOWER EXT W/O DYE | $2,199 | $2,199 | — | — | 4 |
| 3500005 | HC CTA CHEST | $2,066 | $2,066 | — | — | 5 |
| 40801 | Leuprolide Acetate (6 Month) For Subcutaneous Inj Kit 45 MG | $2,035 | $2,035 | — | — | 4 |
| 3500003 | HC CTA HEAD | $2,032 | $2,032 | — | — | 8 |
| PC3100060 | PC MESH: IMPLANTABLE | $1,943 | $1,943 | — | — | 2 |
| 6100031 | HC MRI-ABDOMEN W/O DYE | $1,930 | $1,930 | — | — | 1 |
| PC86366 | PC MUSK AUTOANTIBODY, S | $1,775 | $1,775 | — | — | 1 |
| 6100020 | HC MRI-UPPER EXT JOINT W/O DYE | $1,773 | $1,773 | — | — | 7 |
| 6100027 | HC MRI-LOWER EXT JOINT W/O DYE | $1,773 | $1,773 | — | — | 8 |
| 3520002 | HC CT THORAX W+WO CONTRAST | $1,750 | $1,750 | — | — | 1 |
| 3520005 | HC CT PELVIS W/DYE | $1,724 | $1,724 | — | — | 1 |
| 6110001 | HC MRI-BRAIN/BRAIN STEM | $1,717 | $1,717 | — | — | 3 |
| 3510003 | HC CT ORBITS/FOSSA/SELLA/IAC | $1,653 | $1,653 | — | — | 2 |
| 6120000 | HC MRI-C-SPINE W/O DYE | $1,649 | $1,649 | — | — | 6 |
Showing top 50 of 765 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.